Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Conference item |
| Språk: | English |
| Publicerad: |
American Heart Association
2022
|
| Sammanfattning: |
|---|